Clinical Trial

Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2026 (before its estimated July 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?
Trial Details
NCT Number NCT07407491
Lead Sponsor National University of Malaysia
Conditions Acute Cholangitis, Biliary Tract Infection, Biliary Obstruction, Choledocholithiasis, Malignant Biliary Stricture
Enrollment 172 participants
Start Date 2024-07-09
Primary Completion 2026-07-08 (estimated)
Study Completion 2026-07-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-12